These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34247489)

  • 1. ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy.
    Feyen E; Ricke-Hoch M; Van Fraeyenhove J; Vermeulen Z; Scherr M; Dugaucquier L; Viereck J; Bruyns T; Thum T; Segers VFM; Hilfiker-Kleiner D; De Keulenaer GW
    Circ Heart Fail; 2021 Jul; 14(7):e006898. PubMed ID: 34247489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In peripartum cardiomyopathy plasminogen activator inhibitor-1 is a potential new biomarker with controversial roles.
    Ricke-Hoch M; Hoes MF; Pfeffer TJ; Schlothauer S; Nonhoff J; Haidari S; Bomer N; Scherr M; Stapel B; Stelling E; Kiyan Y; Falk C; Haghikia A; Binah O; Arany Z; Thum T; Bauersachs J; van der Meer P; Hilfiker-Kleiner D
    Cardiovasc Res; 2020 Sep; 116(11):1875-1886. PubMed ID: 31711127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy.
    Halkein J; Tabruyn SP; Ricke-Hoch M; Haghikia A; Nguyen NQ; Scherr M; Castermans K; Malvaux L; Lambert V; Thiry M; Sliwa K; Noel A; Martial JA; Hilfiker-Kleiner D; Struman I
    J Clin Invest; 2013 May; 123(5):2143-54. PubMed ID: 23619365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy.
    Pfeffer TJ; Mueller JH; Haebel L; Erschow S; Yalman KC; Talbot SR; Koenig T; Berliner D; Zwadlo C; Scherr M; Hilfiker-Kleiner D; Bauersachs J; Ricke-Hoch M
    ESC Heart Fail; 2023 Feb; 10(1):465-477. PubMed ID: 36300679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
    Nonhoff J; Ricke-Hoch M; Mueller M; Stapel B; Pfeffer T; Kasten M; Scherr M; von Kaisenberg C; Bauersachs J; Haghikia A; Hilfiker-Kleiner D
    Cardiovasc Res; 2017 May; 113(6):598-608. PubMed ID: 28453725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy.
    Stapel B; Kohlhaas M; Ricke-Hoch M; Haghikia A; Erschow S; Knuuti J; Silvola JM; Roivainen A; Saraste A; Nickel AG; Saar JA; Sieve I; Pietzsch S; Müller M; Bogeski I; Kappl R; Jauhiainen M; Thackeray JT; Scherr M; Bengel FM; Hagl C; Tudorache I; Bauersachs J; Maack C; Hilfiker-Kleiner D
    Eur Heart J; 2017 Feb; 38(5):349-361. PubMed ID: 28201733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perhexiline treatment improves toxic effects of β-adrenergic receptor stimulation in experimental peripartum cardiomyopathy.
    Pfeffer TJ; List M; Müller JH; Scherr M; Bauersachs J; Hilfiker-Kleiner D; Ricke-Hoch M
    ESC Heart Fail; 2021 Aug; 8(4):3375-3381. PubMed ID: 34002539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Vascular Endothelial Function in Young and Middle-Aged Women with Respect to a History of Pregnancy, Pregnancy-Related Complications, Classical Cardiovascular Risk Factors, and Epigenetics.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31936594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes Mellitus and Cardiovascular Risk Assessment in Mothers with a History of Gestational Diabetes Mellitus Based on Postpartal Expression Profile of MicroRNAs Associated with Diabetes Mellitus and Cardiovascular and Cerebrovascular Diseases.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32244558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute doxorubicin cardiotoxicity is associated with miR-146a-induced inhibition of the neuregulin-ErbB pathway.
    Horie T; Ono K; Nishi H; Nagao K; Kinoshita M; Watanabe S; Kuwabara Y; Nakashima Y; Takanabe-Mori R; Nishi E; Hasegawa K; Kita T; Kimura T
    Cardiovasc Res; 2010 Sep; 87(4):656-64. PubMed ID: 20495188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gestational hypertension, preeclampsia and intrauterine growth restriction induce dysregulation of cardiovascular and cerebrovascular disease associated microRNAs in maternal whole peripheral blood.
    Hromadnikova I; Kotlabova K; Hympanova L; Krofta L
    Thromb Res; 2016 Jan; 137():126-140. PubMed ID: 26632513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers in Peripartum Cardiomyopathy-What We Know and What Is Still to Be Found.
    Kryczka KE; Demkow M; Dzielińska Z
    Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A History of Preterm Delivery Is Associated with Aberrant Postpartal MicroRNA Expression Profiles in Mothers with an Absence of Other Pregnancy-Related Complications.
    Hromadnikova I; Kotlabova K; Krofta L
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33919834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AK003290 Protects Myocardial Cells Against Apoptosis and Promotes Cardiac Function Recovery Via miR-539-3p/
    Tang Y; Tang Y; Xiang Y; Yan J; Guo K
    DNA Cell Biol; 2021 Dec; 40(12):1528-1538. PubMed ID: 34931871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opposing roles of Akt and STAT3 in the protection of the maternal heart from peripartum stress.
    Ricke-Hoch M; Bultmann I; Stapel B; Condorelli G; Rinas U; Sliwa K; Scherr M; Hilfiker-Kleiner D
    Cardiovasc Res; 2014 Mar; 101(4):587-96. PubMed ID: 24448315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-1-3p that correlates with left ventricular function of HCM can serve as a potential target and differentiate HCM from DCM.
    Li M; Chen X; Chen L; Chen K; Zhou J; Song J
    J Transl Med; 2018 Jun; 16(1):161. PubMed ID: 29885652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Qiliqiangxin Attenuates Phenylephrine-Induced Cardiac Hypertrophy through Downregulation of MiR-199a-5p.
    Zhang H; Li S; Zhou Q; Sun Q; Shen S; Zhou Y; Bei Y; Li X
    Cell Physiol Biochem; 2016; 38(5):1743-51. PubMed ID: 27161004
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postpartum profiling of microRNAs involved in pathogenesis of cardiovascular/cerebrovascular diseases in women exposed to pregnancy-related complications.
    Hromadnikova I; Kotlabova K; Dvorakova L; Krofta L
    Int J Cardiol; 2019 Sep; 291():158-167. PubMed ID: 31151766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
    Vegter EL; Ovchinnikova ES; Silljé HHW; Meems LMG; van der Pol A; van der Velde AR; Berezikov E; Voors AA; de Boer RA; van der Meer P
    PLoS One; 2017; 12(5):e0177242. PubMed ID: 28475616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-23a-3p Is Upregulated in Plasma Exosomes of Bulbar-onset ALS Patients and Targets ERBB4.
    Liu Y; Ding M; Pan S; Zhou R; Yao J; Fu R; Yu H; Lu Z
    Neuroscience; 2023 Aug; 524():65-78. PubMed ID: 37290686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.